TARO News Alert Taro Pharm Inds (TARO) 144.58 12/25/2014 15:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Taro Pharm Inds (TARO) 144.58 $TARO

Taro Announces Results of Its Annual General Meeting of Shareholders
Business Wire - Wed Dec 24, 12:30PM CST
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company" announced that the Company held its annual general meeting of shareholders on December 22, 2014, at the offices of Meitar Liquornik Geva Leshem Tal, located at 16 Abba Hillel Road, Gallery Floor, Ramat Gan (the "Annual General Meeting" .
TARO: 144.58 (+3.14)

Stock Movers: Why 4 Big Drug Stocks Are Rising Today
at Investor's Business Daily - Tue Nov 18, 1:38PM CST
Drugmakers clustered near the top of IBD's Stocks On The Move list Tuesday afternoon. Actavis (ACT), an Ireland-based maker of generic and branded drugs, shot up more than 7% in huge volume in Tuesday afternoon trading on the stock market today. That...
AGN: 210.12 (+0.95), VRX: 140.33 (-0.22), ACT: 254.20 (-1.68), TARO: 144.58 (+3.14), GILD: 91.29 (+1.84)

Taro Pharmaceutical Industries' (TARO) CEO Kal Sundaram on Q2 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 2:07PM CST

TARO: 144.58 (+3.14)

Taro Pharma ups earnings 49% in FQ2
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 12:48PM CST

TARO: 144.58 (+3.14)

Taro Pharmaceutical EPS of $3.35
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 7:43AM CST

TARO: 144.58 (+3.14)

Taro Provides Results for September 30, 2014
Business Wire - Sun Nov 09, 10:36AM CST
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company" today provided unaudited financial results for the three months and six months ended September 30, 2014.
TARO: 144.58 (+3.14)

Taro reports November 9
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 3:42PM CST

TARO: 144.58 (+3.14)

Taro to Announce Second Quarter Results on November 9, 2014
Business Wire - Wed Nov 05, 2:26PM CST
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2014, on Sunday, November 9, 2014.
TARO: 144.58 (+3.14)

Use The Relative Strength Line To Qualify A Breakout
at Investor's Business Daily - Wed Oct 29, 5:40PM CDT
Stock charts are a collection of facts and tools: price, volume, moving averages. All of them help you understand how a stock and its investors are responding to market input and supply and demand. One very helpful but often lesser-used tool is the...
TARO: 144.58 (+3.14)

Glaucoma Market Analysis 2014-2015 - API Manufacturers and Phase III Pipeline Assessment
M2 - Thu Oct 02, 4:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qn2l4v/glaucoma_market) has announced the addition of the "Glaucoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014" report to their offering. Glaucoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclusivity details of all the drugs across the indication. Key Topics Covered: - Indication Overview - Marketed Drugs Assessment - Marketed Details of Drugs by Application Type - Marketed Details of Drugs (NDA) by Marketing Status - Marketed Details of Drugs by Patent Expiration Timeline - The Active Pharmaceutical Ingredient (API) Manufacturers Assessment - The API Manufacturers by the United States Drug Master File (US DMF) Status - The API Manufacturers by the US DMF Status (Drug Specific) - The Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs - The API Manufacturers by the US DMF Status (Drug Specific) - Drugs Market Data and Forecasted Sales Figures (2011-2015) - Marketed Drugs Information - Drugs Description - Route of Synthesis - Global Active Pharmaceutical Manufacturers - Approval Status - Patent and Exclusivity Details - Company Overview - Phase III Drugs Information - Phase III Drugs Description - The United States Drug Master Filings (US DMF) - Discontinued Drugs Information Companies Mentioned - Allergan, Inc. - Merck & Co., Inc. - Alcon, Inc. - Taro Pharmaceutical Industries Ltd. - Pharmacia & Upjohn, Inc. - Teva Pharmaceuticals USA, Inc. - Akorn, Inc. - Pfizer Inc. - Alcon Laboratories, Inc. - Bausch & Lomb Incorporated - JHP Pharmaceuticals, LLC - Mobius Therapeutics, LLC - American Regent, Inc. For more information visit http://www.researchandmarkets.com/research/qn...oma_market
AGN: 210.12 (+0.95), TARO: 144.58 (+3.14), AKRX: 36.47 (+0.43), PFE: 31.42 (-0.03), MRK: 57.46 (+0.25)

Taro Provides Results for Quarter Ended June 2014
Business Wire - Thu Aug 07, 5:47PM CDT
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company" today provided unaudited financial results for the three month period ended June 30, 2014.
TARO: 144.58 (+3.14)

Taro to Announce Results for Quarter Ended June 30, 2014
Business Wire - Mon Aug 04, 4:05PM CDT
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2014 after market close on Thursday, August 7, 2014.
TARO: 144.58 (+3.14)

4 Stocks Spiking on Big Volume
at The Street - Thu Jul 31, 8:03AM CDT
Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
TARO: 144.58 (+3.14), PNRA: 171.31 (-0.60), EPAY: 25.23 (-0.04), EEFT: 57.80 (+2.14)

Israel's Market Appears Unfazed By Rising Conflict
at Investor's Business Daily - Tue Jul 22, 5:07PM CDT
The conflict between Israel and Palestinians caused the U.S. Federal Aviation Administration on Tuesday to temporarily ban American flights to and from Tel Aviv's Ben Gurion International Airport after a rocket landed near the facility. The airport...
PRGO: 166.11 (+1.96), CSTE: 60.12 (+0.12), EIS: 46.92 (-0.19), TARO: 144.58 (+3.14), ISRA: 29.60 (+0.13), TSEM: 12.61 (+0.07), TEVA: 57.09 (+0.33), MLNX: 43.89 (+0.14), CHKP: 80.44 (+0.51)

Taro Annual Report For Fiscal Year Ended March 31, 2014 on Form 20-F Available
Business Wire - Tue Jul 08, 6:42PM CDT
Taro Pharmaceutical Industries Ltd. (NYSE: TARO, "Taro" announced that its Annual Report for fiscal year ended March 31, 2014 on Form 20-F, filed with the Securities and Exchange Commission (the "SEC" , is available within the Investor Relations section of Taro's website at www.taro.com. Hard copies of the report may be ordered free of charge by sending requests to Taro Pharmaceuticals U.S.A., Inc., Three Skyline Drive, Hawthorne, NY 10532, attention: William J. Coote or via email to William.Coote@Taro.com.
TARO: 144.58 (+3.14)

NYSE stocks posting largest percentage increases
AP - Fri Jun 27, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
BTH: 8.67 (+0.03), NWHM: 14.00 (-0.01), SFE: 20.09 (unch), TRR: 6.40 (-0.08), AZZ: 46.72 (-0.07), EGO: 5.97 (+0.18), TARO: 144.58 (+3.14), ELD.TO: 6.97 (+0.25), PKE: 25.02 (-0.58), MTW: 20.06 (-0.25), GNI: 18.28 (+0.18)

Novo, Other Medicals Display Healthy Action
at Investor's Business Daily - Thu Jun 26, 5:41PM CDT
Leaders in buy range could get tougher to find as the market uptrend continues and stocks break out to new highs. But a raft of medical plays in today's Your Weekly Review are showing fairly healthy action as they work on bases or move near buy...
ACT: 254.20 (-1.68), MYGN: 36.50 (+0.28), NVO: 43.80 (+1.08), TARO: 144.58 (+3.14), SLXP: 114.92 (-1.18), ILMN: 186.22 (+2.72), MYL: 56.97 (+0.39)

3 Stocks Boosting The Health Care Sector Higher
at The Street - Thu Jun 26, 12:02PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today.
TARO: 144.58 (+3.14), ABBV: 66.21 (+1.86), FMS: 37.40 (+0.15)

Why I'm Avoiding Taro Pharmaceuticals
Nathaniel Calloway, The Motley Fool - Motley Fool - Fri Jun 13, 4:14PM CDT
Based purely on financial metrics, Taro Pharmaceuticals   looks like a great investment. Taro is Israeli generic and branded pharmaceutical maker focused primarily on dermatology and skincare that has been undergoing unprecedented growth in the...
TARO: 144.58 (+3.14)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

ISDN Holdings: Leading APAC Automation with Innovation

Updated Category News Views 81

Pioneering Automation Intelligence in APAC Not every day you hear a company quietly revolutionizing an entire industry's landscape—but ISDN Holdings Limited is one of those rare players. Recognized by Frost & Sullivan for its top-tier customer value leadership, ISDN is making waves across the Asia-Pacific's industrial scene with its integrated industrial automation...

Continue Reading
Wonder Create: Democratizing Restaurant Creation

Updated Category News Views 123

Breaking Down Barriers in the Restaurant Industry It's been a long time since someone truly shook up the restaurant scene like this. Wonder Create is stepping in to turn anyone with a wild food idea into a bonafide restaurateur. We're not talking about the ol' franchising route here. We're diving straight into democratizing the culinary world. You seen something this bold...

Continue Reading
ASUS Brings AI Infrastructure Choices to SC26 Floor

Updated Category News Views 257

Compute buyers are sick of being handed one locked box That is the nerve ASUS is pressing at SC26: enterprises want AI infrastructure that fits the job in front of them, not somebody else's tidy product roadmap. The company is pitching a full-stack “AI Factory” blueprint built across Intel, AMD and NVIDIA hardware, running from rack-scale systems and conventional...

Continue Reading
Stand Out For Good Makes a Bold Michigan Avenue Bet

Updated Category News Views 183

A six-floor retail commitment lands with a thud Stand Out For Good is taking on roughly 51,079 square feet at 669 North Michigan Avenue, and nobody should mistake that for a casual expansion. Six levels on Chicago's Magnificent Mile is a proper declaration of intent, especially in a retail district that has endured plenty of empty-window handwringing and big-brand churn....

Continue Reading
Palm Beach Loan Company Tests Luxury Lending Demand

Updated Category News Views 68

Jewelry in a safe is dead capital until somebody lends against it. That plain fact sits behind Luxury Asset Capital's latest move: the launch of Palm Beach Loan Company, a South Florida brand aimed at wealthy owners of watches, diamonds, art, handbags, gold, collectibles, and other high-value possessions. The company is not asking clients to sell the stuff they spent...

Continue Reading
Knotch Bets Brands Need Answers, Not More Web Pages

Updated Category News Views 147

Pages are starting to look like expensive filing cabinets A website that cannot answer an agent may soon be expensive wallpaper. That is the blunt premise behind Knotch's Ace for Agents, launched Nov. 17, 2026, and frankly it lands because plenty of big companies have spent years piling pages atop pages until nobody can tell which claim is current. Knotch is pitching an...

Continue Reading
BNY's December Conference Slot Merits a Careful Listen

Updated Category News Views 118

A 10:40 a.m. conference appearance can look like wallpaper on a market calendar, but BNY's scheduled December 9 discussion deserves more attention than that. Robin Vince, the chief executive, is set to speak at the Goldman Sachs Financial Services Conference in New York, and the company has plainly warned that the conversation may include forward-looking statements and...

Continue Reading
PSEG Declares $0.67 Fourth-Quarter 2026 Cash Dividend

Updated Category News Views 94

A 67-cent utility dividend rarely sets the tape on fire, and that is precisely the point. Public Service Enterprise Group declared a regular fourth-quarter 2026 common-stock dividend of $0.67 per share, payable on or before December 31 to shareholders of record on December 10. For owners of NYSE:PEG, this is the sort of announcement that belongs in the “steady as she...

Continue Reading
Auria, LSAS Team Up: Japan Space Frontier Beckons

Updated Category News Views 105

Pioneering Ventures in Japan's Space Race Watch out, folks—Auria and LSAS Tec have something cooking. One's a titan in space technology, and the other's a maestro in mission analysis. They're joining forces to tango in Japan's booming space market. If you're into the street-smart equity dance, this partnership ain't just chatter over coffee; it's a leap toward new...

Continue Reading
Historic China-Russia-US Summit Aims for Global Stability

Updated Category News Views 71

The Weight of History in Shenzhen When the big players decide to talk face-to-face, it's more than just a photo op. This week in Shenzhen, the leaders of China, Russia, and the United States are doing just that. And let me tell you, it's the kind of gathering that can either stabilize the gears of global politics or grease the wheels of tension. This chinwag isn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Nokia and Microscan Collaborate for Enhanced Optical Networks

Updated Category News Views 262

Nokia and Microscan Join Forces for Optical Network Enhancement Nokia and Microscan have teamed up to create a high-capacity metro and regional optical network in Western India, marking a significant advancement in regional connectivity. This collaboration targets boosting bandwidth and improving overall network reliability for a variety of customers, including...

Continue Reading
Southland Secures $160 Million Credit Facility for Expansion

Updated Category News Views 80

Southland Holdings Enters $160 Million Credit Facility Southland Holdings, Inc. (NYSE American: SLND and SLND WS), recognized as a leader in specialized infrastructure construction services, has successfully closed a new senior secured credit facility valued at $160 million. This new financial arrangement includes an initial draw term loan of $140 million and a delayed...

Continue Reading
Discover the Benefits of the New ezPaycheck Payroll Network

Updated Category News Views 199

Introducing the ezPaycheck Network Version for Businesses The ezPaycheck payroll software has released its 2025 network version, aimed at enhancing productivity for growing companies and remote workers. This update brings numerous advantages, ensuring businesses can efficiently manage payroll, regardless of where their team operates. Key Features of the ezPaycheck Network...

Continue Reading
Nokian Tyres' Profits Surge Amidst Flat Market

Updated Category News Views 60

Profit Spike Fueled by Strategic Moves Amid an insipid global tire market shaking with economic jitters, Nokia’s own Nokian Tyres somehow pulled a rabbit out of a hat. If this isn’t proof that strategy and perseverance pay off, what else is? This Finnish giant just rolled in with earnings that shout, 'We’re doing something right!' Let’s break down how they fared...

Continue Reading
CGI Enhances Veteran Support with MyWWP Connection Portal

Updated Category News Views 139

CGI Partners with Wounded Warrior Project to Help Veterans CGI (TSX: GIB.A) (NYSE: GIB), a leader in IT and business consulting, is proud to announce its collaboration with the Wounded Warrior Project to develop MyWWP, a robust digital portal dedicated to supporting wounded veterans and their families. This enhanced online platform is designed to connect users with...

Continue Reading